FDA Advisers Recommend Making Peptides BPC-157 and TB-500 Available in the U.S.

← SIGNALS[MONEY]
FDA Advisers Recommend Making Peptides BPC-157 and TB-500 Available in the U.S.Most FDA advisers are in favor of making peptides like BPC-157 and TB-500 available in the U.S., which could significantly impact patient access to these therapies.
Editorial Staff / July 23, 2026 / 1 MIN READ / 

In a recent advisory meeting, most FDA advisers expressed support for the availability of peptides BPC-157 and TB-500 in the United States. This decision could pave the way for broader access to these therapies for patients.

The FDA is currently evaluating whether seven specific peptides can be legally compounded, which would allow pharmacies to prepare these medications for individual patients.

If approved, this ruling could enhance treatment options for various conditions, as peptides have shown promise in areas such as healing and recovery.